Group A (Flexibar®) | Group B (Flexibar®+XCO®) | Chi-square test | |
---|---|---|---|
Basic characteristics | |||
Gender | m = 15; f = 24 | m = 17; f = 15 | 0.217 |
Age [years] | 47 ± 8 | 47 ± 8 | 0.173 |
Weight [kg] | 72 ± 15 | 76 ± 12 | 0.300 |
Height [cm] | 173 ± 8 | 175 ± 10 | 0.006 |
BMI | 24.2 ± 4.3 | 24.7 ± 3.5 | 0.352 |
Underlying diseases | |||
Nicotine abuse | 15% | 13% | 0.728 |
Diabetes | 3% | 0% | 0.362 |
Hypercholesterolemia | 8% | 9% | 0.800 |
Hypertension | 8% | 13% | 0.499 |
Heart disease | 0% | 3% | 0.266 |
Intake of acetylsalicylic acid | 5% | 6% | 0.838 |
Intake of cortisone (spray) | 3% | 13% | 0.103 |
Diseases of the elbow | |||
Family disposition | neg. = 29; pos. = 10 | neg. = 27; pos. = 5 | 0.341 |
Pain of right elbow | 74% | 69% | 0.539 |
Pain of left elbow | 5% | 13% | 0.539 |
Bilateral pain of elbow | 21% | 19% | 0.539 |
Morning stiffness | 33% | 28% | 0.585 |
Swelling | 15% | 13% | 0.695 |
Pressure pain | 90% | 88% | 0.522 |
Duration of pain | > 27 weeks | > 27 weeks | 0.485 |
Pain in the morning [VAS] | 2.7 ± 2.2 | 2.5 ± 1.8 | 0.465 |
Daily maximum of pain [VAS] | 5.2 ± 1.8 | 4.7 ± 2.2 | 0.076 |
Intake of antibiotics (Ciprobay, Tavanic) | 3% | 0% | 0.362 |
Previous therapies | |||
Massage | 51% | 41% | 0.424 |
Cross friction | 38% | 16% | 0.060 |
Heat application | 18% | 22% | 0.102 |
Cold application | 44% | 38% | 0.371 |
Shock wave | 15% | 13% | 0.111 |
Eccentric training | 8% | 0% | 0.066 |
Sclerotherapy | 0% | 3% | 0.126 |
Injection of corticosteroids | 56% | 63% | 0.475 |
Injection of Traumeel | 10% | 0% | 0.025 |
Surgical treatment | 3% | 6% | 0.311 |
Bandage | 79% | 72% | 0.169 |
Taping | 10% | 16% | 0.176 |
Kinesiology taping | 10% | 9% | 0.050 |
Collateral tendon diseases | 0.369 | ||
Pain of the patella tendon | 5% | 9% | |
Pain of the Achilles tendon | 0% | 6% | |
Sulcus ulnaris syndrome | 3% | 3% |